New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
Authors
Keywords
COVID-19, Roflumilast, cAMP, Neprilysin, IL-6-Induced endothelial dysfunction, Neutrophil-mediated inflammation, TGF-β1-induced pulmonary fibrosis
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 889, Issue -, Pages 173615
Publisher
Elsevier BV
Online
2020-10-01
DOI
10.1016/j.ejphar.2020.173615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19
- (2020) Y Song et al. GUT
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths
- (2020) Chih-Cheng Lai et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Glucocorticoid Receptor α Mediates Roflumilast’s Ability to Restore Dexamethasone Sensitivity in COPD
- (2020) Aravind T Reddy et al. International Journal of Chronic Obstructive Pulmonary Disease
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- COVID-19 presenting as stroke
- (2020) Akshay Avula et al. BRAIN BEHAVIOR AND IMMUNITY
- Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
- (2020) Lee S. Nguyen et al. CIRCULATION
- Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
- (2020) Fabrizio Dal Moro et al. CLINICAL IMMUNOLOGY
- Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis
- (2020) Sanjeeva Silva et al. CLINICAL MEDICINE
- Possible link between anosmia and COVID-19: sniffing out the truth
- (2020) Annalisa Marinosci et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- A Review of Coronavirus Disease-2019 (COVID-19)
- (2020) Tanu Singhal INDIAN JOURNAL OF PEDIATRICS
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
- (2020) Adewale Bayode Owa et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- (2020) Elissa Driggin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- “Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
- (2020) Alexandre Gérard et al. THERAPIE
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
- (2020) Ping Wu et al. JAMA Ophthalmology
- Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
- (2020) Chin Kook Rhee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Immunotherapies for COVID-19: lessons learned from sepsis
- (2020) Kenneth E Remy et al. Lancet Respiratory Medicine
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
- (2020) Douglas B. Kell et al. Frontiers in Immunology
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
- (2020) Yuhao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Repurposed GI Drugs in the Treatment of COVID-19
- (2020) Enrik John T. Aguila et al. DIGESTIVE DISEASES AND SCIENCES
- Tocilizumab administration in a refractory case of COVID-19
- (2020) Farzaneh Dastan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
- (2020) Arianna Pani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
- (2020) Jun He et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases
- (2020) Keisuke Iwabuchi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Why are pregnant women susceptible to COVID-19? An immunological viewpoint
- (2020) Hong Liu et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- The powerful immune system against powerful COVID-19: A hypothesis
- (2020) Farzad Taghizadeh-Hesary et al. MEDICAL HYPOTHESES
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Rethinking high-risk groups in COVID-19
- (2020) Anastasia Vishnevetsky et al. Multiple Sclerosis and Related Disorders
- Septic shock presentation in adolescents with COVID-19
- (2020) Cecilia Dallan et al. Lancet Child & Adolescent Health
- Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?
- (2020) Jinglu Lyu et al. MEDICAL HYPOTHESES
- Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study
- (2019) Ijeoma M Muo et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Mitochondria as a possible target for nicotine action
- (2019) Dominika Malińska et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Effect of roflumilast on chronic obstructive pulmonary disease: a systematic review and meta-analysis
- (2018) Lu-Fei Shen et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Inflammaging: a new immune–metabolic viewpoint for age-related diseases
- (2018) Claudio Franceschi et al. Nature Reviews Endocrinology
- Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
- (2018) Klaus F Rabe et al. Lancet Respiratory Medicine
- Direct Inhibitory Effect of the Phosphodiesterase-4 Inhibitor, Roflumilast, on Neutrophil Migration in COPD
- (2018) Amy E Dunne et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Deep insight into neutrophil trafficking in various organs
- (2017) Young-Min Hyun et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice
- (2017) Hongfang Feng et al. LABORATORY INVESTIGATION
- Roles of IL-6 in Ocular Inflammation: A Review
- (2017) Hassan Ghasemi OCULAR IMMUNOLOGY AND INFLAMMATION
- Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges
- (2017) Yuichi Hattori et al. PHARMACOLOGY & THERAPEUTICS
- Cytokine storms in infectious diseases
- (2017) John R. Teijaro Seminars in Immunopathology
- Coagulation and sepsis
- (2017) Marcel Levi et al. THROMBOSIS RESEARCH
- Inflammatory responses and inflammation-associated diseases in organs
- (2017) Linlin Chen et al. Oncotarget
- Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases
- (2017) Theerasuk Kawamatawong Journal of Thoracic Disease
- cAMP regulates the functional activity, coupling efficiency and structural organization of mammalian F O F 1 ATP synthase
- (2016) Domenico De Rasmo et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis
- (2016) Paola Rogliani et al. Expert Opinion On Drug Safety
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
- (2016) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease
- (2016) Hongpeng Jia SHOCK
- The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
- (2016) Verena Katharina Raker et al. Frontiers in Immunology
- The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis
- (2016) Andrew S. Kimball et al. Frontiers in Immunology
- Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1
- (2016) Peter J. Wermuth et al. PLoS One
- ABCD of the phosphodiesterase family: interaction and differential activity in COPD
- (2016) David Halpin International Journal of Chronic Obstructive Pulmonary Disease
- (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression
- (2015) Xiang Chang et al. EXPERIMENTAL CELL RESEARCH
- The Specific Roles of JAK/STAT Signaling Pathway in Sepsis
- (2015) Bin Cai et al. INFLAMMATION
- Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes
- (2015) L. Totani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial
- (2015) Fernando J Martinez et al. LANCET
- An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
- (2015) Vijay U. Rao et al. Arthritis & Rheumatology
- Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model
- (2015) Javier Milara et al. PLoS One
- The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
- (2014) Agata Kowalczyk et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cellsin vitro
- (2014) Javier Milara et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
- (2014) Monalisa F. Azevedo et al. ENDOCRINE REVIEWS
- Interleukin 6 in Hyposmia
- (2014) Robert I. Henkin et al. JAMA Otolaryngology-Head & Neck Surgery
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
- (2013) William B. White et al. CHEST
- Angiotensin Peptides and Nitric Oxide in Cardiovascular Disease
- (2012) Kaushik P. Patel et al. ANTIOXIDANTS & REDOX SIGNALING
- cAMP and Epac in the regulation of tissue fibrosis
- (2012) Paul A Insel et al. BRITISH JOURNAL OF PHARMACOLOGY
- The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice
- (2012) S. Vollert et al. DIABETOLOGIA
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Molecular Mechanisms of N-Formyl-Methionyl-Leucyl-Phenylalanine-Induced Superoxide Generation and Degranulation in Mouse Neutrophils: Phospholipase D Is Dispensable
- (2012) T. Sato et al. MOLECULAR AND CELLULAR BIOLOGY
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
- (2011) Klaus F. Rabe BRITISH JOURNAL OF PHARMACOLOGY
- The role of IL-10 in immune regulation during M. tuberculosis infection
- (2011) P S Redford et al. Mucosal Immunology
- Angiotensin-(1–7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger
- (2010) Amin Shah et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Decreased Neprilysin and Pulmonary Vascular Remodeling in Chronic Obstructive Pulmonary Disease
- (2010) Marilee J. Wick et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neutrophils in chronic inflammatory airway diseases: can we target them and how?
- (2010) Y. Gernez et al. EUROPEAN RESPIRATORY JOURNAL
- Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells
- (2010) Ming-Jui Hung et al. JOURNAL OF HYPERTENSION
- cAMP Activates The generation of Reactive Oxygen Species and Inhibits The Secretion of IL-6 in Peripheral Blood Mononuclear Cells from Type 2 Diabetic Patients
- (2010) Camila Armond Isoni et al. Oxidative Medicine and Cellular Longevity
- Extracellular DNA traps promote thrombosis
- (2010) T. A. Fuchs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGF 1-induced fibroblast differentiation into myofibroblasts
- (2010) N. Amara et al. THORAX
- PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-β1-stimulated fibroblasts
- (2009) Shinsaku Togo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Inflammatory cytokines in vascular dysfunction and vascular disease
- (2009) Alexander H. Sprague et al. BIOCHEMICAL PHARMACOLOGY
- Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People
- (2009) Preeti Gupta et al. DRUGS & AGING
- Neutrophil-derived serine proteases modulate innate immune responses
- (2009) Ulf Meyer-Hoffert Frontiers in Bioscience-Landmark
- Estrogen Regulation of the Neprilysin Gene Through A Hormone-Responsive Element
- (2009) Zhi-Min Xiao et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages
- (2009) A. L. Hertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgens regulate neprilysin expression: role in reducing β-amyloid levels
- (2008) Mingzhong Yao et al. JOURNAL OF NEUROCHEMISTRY
- Unknown
- (2008) Rodrigo Fraga-Silva et al. MOLECULAR MEDICINE
- Influence of Selected Natural Products on Neutral Endopeptidase Activity and β-Amyloid Production in SK-N-SH Cells
- (2008) Shereen Ayoub et al. PHARMACEUTICAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More